Delivery Order 19AQMM23D0093-19AQMM25F1560
Award Date 9/30/24
Potential Completion Date 9/29/25
Potential Value $993K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
St. Louis, MO 63146, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Office of the Assistant Secretary for Administration awarded a $418,637.55 firm-fixed-price purchase order to Meridian Medical Technologies, LLC for DuoDote auto-injectors (FPAE NDC #11704-0620-01) with an ultimate completion date of January 5, 2026. The contract was designated as a Total Small Business set-aside, with performance to be executed in St. Louis, Missouri. Meridian Medical Technologies is a wholly-owned subsidiary of Pfizer Inc. specializing in the development and...
- On September 30, 2024, the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a definitive firm-fixed-price contract to Meridian Medical Technologies, LLC for the supply of Atropine & Pralidoxime Chloride Injector single-dose auto-injectors (DuoDote) for the Strategic National Stockpile. The contract has a ceiling value of approximately $129.7 million with a one-year performance period from September 30, 2025 through...
- This is a firm-fixed-price purchase order contract awarded by the U.S. Secret Service to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., for the purchase of DuoDote auto-injector packs. The contract has a ceiling value of $70,111.80 and a completion date of May 5, 2018. Meridian Medical Technologies has a history of providing medical training devices, auto-injector kits, and nerve agent antidote treatments to various federal agencies, including the Department of...
- This is a firm-fixed-price purchase order awarded by the U.S. Marshals Service Tactical Operations Division to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The $15,514.80 contract is for the delivery of auto-injectors containing the nerve agent antidotes atropine and pralidoxime. The contract does not utilize any set-aside designations. Meridian Medical Technologies is a key provider of auto-injector devices and nerve agent antidote treatments across the federal...
- This federal contract award to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., is for the development and delivery of an FDA-approved advanced autoinjector system (AAS). The definitive contract, valued at $41,936,532.62, is a cost-plus-incentive arrangement with the U.S. Department of Defense's Joint Program Executive Office for Chemical and Biological Defense. The award does not utilize a small business set-aside. Meridian, a manufacturer of medical countermeasures...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injectors on October 7, 2025, with a ceiling value of $12,500.61. This firm fixed-price delivery order is scheduled for completion by October 8, 2025, and represents a pediatric/emergency medical supply need fulfilled through the company's existing contract vehicle. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (two pack) valued at $1,594.92. The contract, awarded July 11, 2025, with a completion date of July 14, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,260.76 and is a Firm Fixed Price Delivery Order with a completion date of July 16, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,989.96 by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Epinephrine 0.3 mg auto-injector pens (2-pack). The order, with an ultimate completion date of September 22, 2025, carries firm fixed pricing with no set-aside designation, indicating it was awarded through open competition. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $2,856.36 and an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million...